 Mainz Biomed N.V. NASDAQ: MYNZ went up by 80 after it announced that it and Socpra Sciences had executed a Technology Rights Agreement in order to gain access to novel mRNA biomarkers with the goal of integrating them into ColoAlert in the future. 